Heptares Therapeutics' Seed VC - II Round

Heptares Therapeutics raised a round of funding on February 25, 2008. Investors include MVM Life Science Partners.

Heptares Therapeutics focuses on the discovery and development of novel drugs acting at G-protein coupled receptors (GPCRs). Heptares StaR (Stabilized Receptor) technology enables thermo-stabilization…

Articles about Heptares Therapeutics' Seed VC - II Round: